NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aresus Pharma

Aresus Pharma

Private
StrausbergHealthcare & Life Scienceshttps://dermago.com/

Last Round

Crowdfunding

Feb 21, 2024

Est. Valuation

$19.01M

Total Funding Raised

$4.59M

Company Overview

Aresus Pharma is a pharmaceutical company that develops, licenses, and distributes prescription dermatology products, including the drug Veregen®.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials

Business Model

B2C

Customer Profile

Services & Consulting, Marketplace Commission

AI Layer

Non-AI

Keywords

dermatology medicinespecialty pharmadrug licensingdrug developmentclinical trialsdrug commercializationdrug asset acquisitionnew indicationsdrug repurposingB2B pharmabotanical drugVeregenactinic keratosisgenital warts treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aresus Pharma Comparables

Compare Aresus Pharma with similar companies based on industry and business-model similarity.

Aresus Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sol-Gel Technologies Ltd.
66%
Almirall
66%
LEO Pharma
64%

Aresus Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingFeb 21, 2024
CrowdfundingJun 28, 2022
CrowdfundingJul 1, 2019

Aresus Pharma Investors

Notable investors and investment history

Aresus Pharma investors
InvestorRounds
Mittelständische Beteiligungsgesellschaft Berlin-BrandenburgCrowdfunding
CompanistoCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 21, 2024

    $1.73M raised from multiple investors.

  • Jun 28, 2022

    Raised $2M in a crowdfunding round.

Aresus Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aresus Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aresus Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersStrausberg
Year Founded2019
Last FundingFeb 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.